The antiobesity drug orlistat [`Xenical'; Roche] has been granted priority review status

Source: Inpharma, Volume 1, Number 1294, 2001 , pp. 22-22(1)

Publisher: Adis International

Keywords: Orlistat, therapeutic use; Regulatory-process; Obesity, treatment; Type-2-diabetes-mellitus

Language: English

Document Type: Short communication

Publication date: 2001-01-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers